Label: BONINE- meclizine hydrochloride tablet, chewable

  • NDC Code(s): 65197-297-08, 65197-297-12, 65197-297-16, 65197-297-24
  • Packager: WellSpring Pharmaceutical Corporation
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated March 21, 2025

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient (in each tablet)

    Meclizine HCl 25 mg

  • Purpose

    Antiemetic

  • Uses

    prevents and treats nausea, vomiting or dizziness associated with motion sickness

  • Warnings

    Do not use 

    in children under 12 years of age unless directed by a doctor.

    Ask a doctor before use if you have

    • difficulty in urination due to enlargement of the prostate gland
    • glaucoma
    • a breathing problem such as emphysema or chronic bronchitis

    Ask a doctor or pharmacist before use if you are

    taking sedatives or tranquilizers.

    When using this product

    • avoid alcoholic beverages
    • alcohol, sedatives, and tranquilizers may increase drowsiness
    • drowsiness may occur
    • use caution when driving a motor vehicle or operating machinery

    If pregnant or breast-feeding, 

    ask a health professional before use.

    Keep out of reach of children. 

    In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    • dosage should be taken one hour before travel starts
    • chew or crush tablets completely before swallowing; do not swallow tablets whole
    • adults and children 12 years and over: take 1 to 2 chewable tablets once daily or as directed by a doctor
  • Other information

    • store at 25˚C (77˚F); excursions permitted between 15˚-30˚C (59˚-86˚F)
    • see end flap for expiration date and lot number
    • protect from heat and humidity
  • Inactive ingredients

    colloidal silicon dioxide, dextrose, FD&C red #40 aluminum lake, flavor, lactose monohydrate, magnesium stearate, pregelatinized starch, propylene glycol, saccharin sodium, silicon dioxide

  • Questions or comments?

    1 (844) 241-5454 or www.bonine.com 

  • Dist. by:

    WellSpring Pharmaceutical
    Corporation Sarasota, FL 34243
    ©2024 WellSpring Pharmaceutical Corporation

    TAMPER EVIDENT: DO NOT USE IF PRINTED TEAR STRIP IS BROKEN OR MISSING

    MONEY BACK GUARANTEE

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL 65197-297

    *Less drowsy vs. Dramamine® dimenhydrinate. Dramamine® is a registered trademark of Medtech Products Inc.

    NEW LOOK! Same great formula

    9X the Adventure** Meclizine HCl • Antiemetic 25 mg

    CT029512RE

    Bonine 12 ct

  • INGREDIENTS AND APPEARANCE
    BONINE 
    meclizine hydrochloride tablet, chewable
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:65197-297
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570) MECLIZINE HYDROCHLORIDE25 mg
    Inactive Ingredients
    Ingredient NameStrength
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    SACCHARIN SODIUM (UNII: SB8ZUX40TY)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    Product Characteristics
    ColorpinkScore2 pieces
    ShapeROUNDSize9mm
    FlavorRASPBERRYImprint Code BONINE
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:65197-297-081 in 1 BOX04/01/2025
    18 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:65197-297-121 in 1 BOX04/01/2025
    212 in 1 BOTTLE; Type 0: Not a Combination Product
    3NDC:65197-297-162 in 1 BOX04/01/2025
    38 in 1 BLISTER PACK; Type 0: Not a Combination Product
    4NDC:65197-297-243 in 1 CARTON04/01/2025
    48 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00904/01/2025
    Labeler - WellSpring Pharmaceutical Corporation (110999054)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!